These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31062234)

  • 1. CRH stimulation improves
    Boyle J; Patronas NJ; Smirniotopoulos J; Herscovitch P; Dieckman W; Millo C; Maric D; Chatain GP; Hayes CP; Benzo S; Scott G; Edwards N; Ray Chaudhury A; Lodish MB; Sharma S; Nieman LK; Stratakis CA; Lonser RR; Chittiboina P
    Endocrine; 2019 Jul; 65(1):155-165. PubMed ID: 31062234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
    Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
    J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin releasing hormone can selectively stimulate glucose uptake in corticotropinoma via glucose transporter 1.
    Lu J; Montgomery BK; Chatain GP; Bugarini A; Zhang Q; Wang X; Edwards NA; Ray-Chaudhury A; Merrill MJ; Lonser RR; Chittiboina P
    Mol Cell Endocrinol; 2018 Jul; 470():105-114. PubMed ID: 28986303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Imaging Targeting Corticotropin-releasing Hormone Receptor for Corticotropinoma: A Changing Paradigm.
    Walia R; Gupta R; Bhansali A; Pivonello R; Kumar R; Singh H; Ahuja C; Chhabra R; Singh A; Dhandapani S; Sahoo S; Rana N; Vatsa R; Dutta P; Kumar Bhadada S; Sachdeva N; Mittal BR; Nahar U; Shukla J
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1816-e1826. PubMed ID: 33079979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential utility of FLAIR in MRI-negative Cushing's disease.
    Chatain GP; Patronas N; Smirniotopoulos JG; Piazza M; Benzo S; Ray-Chaudhury A; Sharma S; Lodish M; Nieman L; Stratakis CA; Chittiboina P
    J Neurosurg; 2018 Sep; 129(3):620-628. PubMed ID: 29027863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome.
    Senanayake R; Gillett D; MacFarlane J; Van de Meulen M; Powlson A; Koulouri O; Casey R; Bashari W; Gurnell M
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101513. PubMed ID: 34045044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome.
    Koulouri O; Steuwe A; Gillett D; Hoole AC; Powlson AS; Donnelly NA; Burnet NG; Antoun NM; Cheow H; Mannion RJ; Pickard JD; Gurnell M
    Eur J Endocrinol; 2015 Oct; 173(4):M107-20. PubMed ID: 26245763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of
    Shukla J; Vatsa R; Walia R; Chhabra A; Rana N; Singh H; Kumar R; Mittal BR
    Cancer Biother Radiopharm; 2021 Oct; 36(8):642-650. PubMed ID: 34191604
    [No Abstract]   [Full Text] [Related]  

  • 10. Utility of hCRH-stimulated (18) F-FDG PET-CT scan in localisation of pituitary microadenoma in Cushing's disease.
    Patt HP; Lele V; Lila A; Bandgar T; Shah N
    J Med Imaging Radiat Oncol; 2014 Apr; 58(2):213. PubMed ID: 24690246
    [No Abstract]   [Full Text] [Related]  

  • 11. Dexamethasone suppression for
    Kim K; Kim DK; Moon JH; Kim EH; Kim SH; Ku CR; Lee EJ
    Cancer Imaging; 2023 Sep; 23(1):85. PubMed ID: 37700359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of fused positron emission tomography/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing's disease.
    Alzahrani AS; Farhat R; Al-Arifi A; Al-Kahtani N; Kanaan I; Abouzied M
    Pituitary; 2009; 12(4):309-14. PubMed ID: 19387839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study.
    Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z
    J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing's syndrome.
    Erickson D; Erickson B; Watson R; Patton A; Atkinson J; Meyer F; Nippoldt T; Carpenter P; Natt N; Vella A; Thapa P
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):793-9. PubMed ID: 19811509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results and predictors of outcome of endoscopic endonasal surgery in Cushing's disease: 20-year experience of an Italian referral Pituitary Center.
    Guaraldi F; Zoli M; Asioli S; Corona G; Gori D; Friso F; Pasquini E; Bacci A; Sforza A; Mazzatenta D
    J Endocrinol Invest; 2020 Oct; 43(10):1463-1471. PubMed ID: 32215861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of composite methionine-positron emission tomography/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma.
    Ikeda H; Abe T; Watanabe K
    J Neurosurg; 2010 Apr; 112(4):750-5. PubMed ID: 19698042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coexistence of infundibular pituicytoma and Cushing's disease due to pituitary adenoma: A case report.
    Gezer E; Selek A; Cetinarslan B; Canturk Z; Tarkun I; Ceylan S
    Endocr Regul; 2019 Oct; 53(4):263-267. PubMed ID: 31734654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
    Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
    Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.